Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium.

Autor: Sánchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Campa D; Department of Genetics, University of Pisa, Pisa, Italy., Springer J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Badiola J; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Niazi Y; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Moñiz-Díez A; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Hernández-Mohedo F; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., González-Sierra P; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Ter Horst R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands., Macauda A; Department of Genetics, University of Pisa, Pisa, Italy.; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brezina S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Cunha C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Guimarães, Portugal., Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., López-Nevot MA; Immunology department, Virgen de las Nieves University Hospital, Granada, Spain., Fianchi L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., Pagano L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., López-Fernández E; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Moratalla L; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Rodríguez-Sevilla JJ; Hematology department, Hospital del Mar, Barcelona, Spain., Fonseca JE; Rheumatology and Metabolic Bone Diseases department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon Academic Medical Center, Lisbon, Portugal., Tormo M; Hematology department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Solano C; Hematology department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Clavero E; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain., Romero A; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain., Li Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany., Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Vazquez L; Hematology department, University Hospital of Salamanca, Salamanca, Spain., Loeffler J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Hemminki K; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany.; Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic., Carvalho A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Guimarães, Portugal., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115, Bonn, Germany., Gsur A; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Dumontet C; Université Claude Bernard Lyon I, Lyon, France., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Försti A; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Jurado M; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain. juan.sainz@genyo.es.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain. juan.sainz@genyo.es.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. juan.sainz@genyo.es.; Department of Medicine, University of Granada, Granada, Spain. juan.sainz@genyo.es.

Publikováno v: Blood cancer journal [Blood Cancer J] 2020 Jul 16; Vol. 10 (7), pp. 75. Date of Electronic Publication: 2020 Jul 16.